BIFIDOBACTERIUM LONGUM FOR TREATING OBESITY AND RELATED METABOLIC DISORDERS Russian patent published in 2021 - IPC C12N1/20 A61K35/745 A61P37/02 

FIELD: biotechnology.

SUBSTANCE: group of inventions can be used in preventing and treating obesity. Disclosed is a strain of bacteria Bifidobacterium longum AH 1362 deposited in NCIMB under registration number 41715, composition, a lyophilized composition for preventing and/or treating obesity from an obesity-associated disease comprising an effective amount of a strain, a food product for preventing obesity, comprising a strain, a composition or a lyophilised composition, and a capsule for preventing and/or treating obesity containing a strain, or a composition, or a lyophilised composition. Composition and lyophilised composition can additionally contain a probiotic, a prebiotic, an orally-received carrier, protein and/or peptide, in particular proteins and/or peptides, which are rich in glutamine/glutamate, a lipid, a carbohydrate, a vitamin, a mineral and/or a microelement, an adjuvant in an effective amount. Carrier can be a capsule, tablet or powder, a food product such as rancid milk, yoghurt, frozen yoghurt, dry milk, a milk concentrate, processed cheeses, sauces or beverages, the strain Bifidobacterium longum NCIMB 41715 is present in amount of 106 CFU/g of the composition; the capsule is adapted to controlled release in the gastrointestinal tract.

EFFECT: group of inventions enables treating obesity, including obesity associated with obesity of metabolic syndrome.

17 cl, 15 dwg, 3 tbl, 5 ex